Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High weight and obesity are associated with poor outcomes in leukemia treatment.

2.

Climate change is expected to increase the number of suicide deaths

3.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot